Rare lephants
Screener

Ionis Pharmaceuticals, Inc.

IONS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Oct 21, 2026 8-K
4 Oct 19, 2026 PRIMARY DOCUMENT
4 Oct 19, 2026 PRIMARY DOCUMENT
144 Oct 16, 2026
8-K Sep 23, 2026 CURRENT REPORT FILING
8-K Sep 4, 2026 8-K
8-K Sep 4, 2026 8-K
4 Sep 2, 2026 PRIMARY DOCUMENT
4 Sep 2, 2026 PRIMARY DOCUMENT
4 Sep 2, 2026 PRIMARY DOCUMENT
4 Sep 2, 2026 PRIMARY DOCUMENT
4 Jul 31, 2026 PRIMARY DOCUMENT
S-8 Jul 31, 2026 S-8
10-Q Jul 29, 2026 IONIS PHARMACEUTICALS, INC. 10-Q 06-30-2026
8-K Jul 29, 2026 8-K
4 Jul 17, 2026 PRIMARY DOCUMENT
4 Jul 17, 2026 PRIMARY DOCUMENT
4 Jul 17, 2026 PRIMARY DOCUMENT
4 Jul 17, 2026 PRIMARY DOCUMENT
8-K Jul 10, 2026 8-K
4 Jul 9, 2026 PRIMARY DOCUMENT
4 Jul 9, 2026 PRIMARY DOCUMENT
4 Jul 9, 2026 PRIMARY DOCUMENT
8-K Jul 9, 2026 8-K
144 Jul 7, 2026
← Newer Page 1 of 106 · 2631 filings Older →